Literature DB >> 2376164

Testing for isoniazid. An evaluation of the Arkansas method.

D E Schraufnagel1, R Stoner, E Whiting, G Snukst-Torbeck, M J Werhane.   

Abstract

To better treat and eliminate tuberculosis, patient compliance must be improved. Compliance can be evaluated by measuring a drug or its metabolite in the urine. In Arkansas, a simple colorimetric method of checking the urine for isoniazid (the Potts-Cozart test) has been used for many years, but it is relatively unknown outside that state and its reliability has not been confirmed. To evaluate this test, urine was blindly tested from patients from a tuberculosis clinic. Controls included urine from patients from a substance abuse clinic and Veterans Medical Center. In more than 200 urine samples tested, no false-positives were found. Urinalysis showed normal values for three patients who were supposed to be receiving antituberculosis medication, but it is likely that these patients were noncompliant. A peculiarity of the test was that the color change with positive tests varied. To investigate this variation, absorption spectroscopy of many substances was performed. Nicotine accounted for the different shade of blue associated with the positive test, but the color produced and the absorption spectroscopy were different from isoniazid, so it did not confuse the interpretation of the results. This test for isoniazid in the urine is simple, quick, inexpensive, easy to interpret, and reliable. It also can be used to detect nicotine and its metabolites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376164     DOI: 10.1378/chest.98.2.314

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  The reliability and practicality of the Arkansas method assay of isoniazid adherence.

Authors:  Katharine E Schmitz; Melbourne F Hovell; Charlene A Wong; Norma J Kelley; Donata Nilsen; Elaine J Blumberg; Linda L Hill; Carol L Sipan; Bo Kolody; Dale A Chatfield
Journal:  Clin Nurs Res       Date:  2010-05       Impact factor: 2.075

2.  Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children.

Authors:  V Amlabu; C Mulligan; N Jele; A Evans; D Gray; H J Zar; H McIlleron; P Smith
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

3.  Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.

Authors:  Renata L Guerra; Marcus B Conde; Anne Efron; Carla Loredo; Gisele Bastos; Richard E Chaisson; Jonathan E Golub
Journal:  Respir Med       Date:  2010-03-03       Impact factor: 3.415

4.  Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs.

Authors:  Sarah J Iribarren; Hannah Milligan; Cristina Chirico; Kyle Goodwin; Rebecca Schnall; Hugo Telles; Alejandra Iannizzotto; Myrian Sanjurjo; Barry R Lutz; Kenneth Pike; Fernando Rubinstein; Marcus Rhodehamel; Daniel Leon; Jesse Keyes; George Demiris
Journal:  Lancet Reg Health Am       Date:  2022-06-10

5.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

6.  Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients.

Authors:  Ioana Nicolau; Lulu Tian; Dick Menzies; Gaston Ostiguy; Madhukar Pai
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.

Authors:  Emily A Kendall; Betina Durovni; Neil A Martinson; Solange Cavalacante; Katlego Masonoke; Valeria Saraceni; Limakatso Lebina; Anne Efron; Silvia Cohn; Sandy Chon; Richard E Chaisson; David W Dowdy; Jonathan E Golub
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

8.  Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.

Authors:  Tom A Szakacs; Douglas Wilson; D William Cameron; Michael Clark; Paul Kocheleff; F James Muller; Anne E McCarthy
Journal:  BMC Infect Dis       Date:  2006-06-13       Impact factor: 3.090

9.  Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial.

Authors:  Sarah Iribarren; Hannah Milligan; Kyle Goodwin; Omar Alfonso Aguilar Vidrio; Cristina Chirico; Hugo Telles; Daniela Morelli; Barry Lutz; Jennifer Sprecher; Fernando Rubinstein
Journal:  JMIR Res Protoc       Date:  2021-06-21

10.  Understanding Nonadherence to Tuberculosis Medications in India Using Urine Drug Metabolite Testing: A Cohort Study.

Authors:  Ramnath Subbaraman; Beena E Thomas; J Vignesh Kumar; Kannan Thiruvengadam; Amit Khandewale; S Kokila; Maya Lubeck-Schricker; M Ranjith Kumar; Gunjan Rahul Gaurkhede; Apurva Shashikant Walgude; J Hephzibah Mercy; Jagannath Dattatraya Kumbhar; Misha Eliasziw; Kenneth H Mayer; Jessica E Haberer
Journal:  Open Forum Infect Dis       Date:  2021-05-05       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.